Apollo Hospitals Enterprise Limited vs Vanta Bioscience Ltd

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Vanta Bioscience Ltd (VANTABIOSCIENCELTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs VANTABIOSCIENCELTD on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability31
  • Growth10
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

APOLLOHOSP takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
137.20
13.46
P/B ratio
0.69
0.22%
Dividend yield
0.00%
₹135.04
EPS
₹0.15

Profitability

APOLLOHOSP takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
0.70%
17.31%
Return on capital
1.19%
14.94%
EBITDA margin
56.04%
7.94%
Net margin
6.04%

Growth

APOLLOHOSP takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
-32.16%
33.35%
Profit CAGR (3Y) even
—

Size & financial health

APOLLOHOSP takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹15 Cr
₹25,229 Cr
Revenue
₹2 Cr
₹2,003 Cr
Net profit
₹0 Cr
0.90
Debt / equity
1.80
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Vanta Bioscience Ltd
  • + ["Company has reduced debt.", "Stock is trading at 0.69 times its book value"]
  • − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -28.6% over past five years.", "Company has a low return on equity of -15.6% over last 3 years.", "Company might be capitalizing the interest cost", "Company has high debtors of 513 days.", "Working capital days have increased from -636 days to 435 days"]
Apollo Hospitals Enterprise Limited full analysis Vanta Bioscience Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLOHOSP vs VANTABIOSCIENCELTD: Share Price, Valuation & Which to Buy | DocStoX